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Abstract
Several lines of experimentation support the view that the genetic, biochemical and bioenergetic functions of somatic
mitochondria deteriorate during normal aging. Deletion mutations of the mitochondrial genome accumulate exponentially
with age in nerve and muscle tissue of humans and multiple other species. In muscle, a tissue that undergoes age-related fiber
loss and atrophy in humans, there is an exponential rise in the number of cytochrome-oxidase-deficient fibers, which is first
detectable in the fourth decile of age. Most biochemical studies of animal mitochondrial activity indicate a decline in electron
transport activity with age, as well as decreased bioenergetic capacity with age, as measured by mitochondrial membrane
potential. Mitochondrial mutations may be both the result of mitochondrial oxidative stress, and cells bearing pure
populations of pathogenic mitochondrial mutations are sensitized to oxidant stress. Oxidant stress to mitochondria is known
to induce the mitochondrial permeability transition, which has recently been implicated in the release of cytochrome c and
the initiation of apoptosis. Thus several lines of evidence support a contribution of mitochondrial dysfunction to the
phenotypic changes associated with aging. ß 1999 Elsevier Science B.V. All rights reserved.
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1. The multifactorial de¢cits of function that
accumulate with age can be understood in an
evolutionary context
The multifactorial decrements of function that oc-
cur during human aging support the view that aging
is the result of a multiple underlying causes. Aging
can be understood in an evolutionary context, in
which natural selection strongly favors genetic varia-
tion that leads to survival to the age of reproduction
[1], whereas positive or negative natural selection for
traits that appear long after the age of reproduction
is weak or neutral [2^7]. Other support for the neu-
trality of genetic variation that underlies aging phe-
notypes comes from the consideration that for most
of the history of modern humans (i.e. since about
140 000 years ago [8,9]) the mean human lifespan
has been much shorter than it currently is, providing
a relatively small pool of elderly individuals on which
selection could act (Fig. 1). Since selection is likely to
be e¡ectively neutral on genetic polymorphisms that
promote or attenuate survival long after the age of
reproduction, the human gene pool is likely to con-
tain substantial genetic variation that controls the
rate of cellular maintenance [10,11]. Genes that pro-
vide for cellular maintenance are likely to include
Fig. 1. Ideogram of the historical age structure of the human population and the intensity of natural selection on genotypes which af-
fect aging phenotypes. US population census data from 1980 and 1840 are redrawn from J.F. Fries, L.M. Crapo, Vitality and Aging,
W.H. Freeman, San Francisco., 1981. The age structure of pre-agricultural human hunter-gatherers is a matter of debate, but infant
mortality (a major in£uence on mean lifespan) is likely to be at least twice as high as in 1840, and adult mortality is likely to be sig-
ni¢cantly increased as well.
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those which protect molecules from damage, includ-
ing genes for DNA repair and protection from oxi-
dant stress. DNA repair of the nuclear and mito-
chondrial genomes, for example, is quite a costly
process in terms of metabolic energy spent. Thus
one might expect the ‘set point’ of DNA repair proc-
esses to provide that genomes should maintain integ-
rity until the age of reproduction, but that natural
selection for maintenance of genomes long after the
age of reproduction should be weak. Thus a corol-
lary prediction of the evolutionary theory of aging is
that the somatic mutations and other defects result-
ing from incomplete cellular maintenance should rise
with age.
2. Nuclear somatic mutations rise in human tissues
with age
There is substantial evidence that the frequency of
nuclear somatic mutations rises with age in non-on-
cogenes using phenotypic selection assays of muta-
genesis [12]. Using a PCR-based method of genotypic
selection, it has been demonstrated that somatic mu-
tations also rise in known oncogenes both with age
and with exposure to carcinogens [13^15]. In animal
models, a two-fold rise in nuclear somatic mutations
with age in somatic mutations with age has been
reported [16].
3. The contribution of mitochondrial de¢cits to aging
phenotypes has been suggested
A contribution of mitochondrial defects to age-re-
lated decline in cellular function of humans and oth-
er animals has been posited [17^25]. Support for a
decline in mitochondrial function with age has come
genetic assays of mitochondrial mutagenesis, and
biochemical assays of mitochondrial function.
3.1. Age-related rise in mtDNA deletion mutagenesis
The mitochondrial genomes of humans [21,26^30],
monkeys [31], rats [32,33], mice [34^36], and nemat-
odes [37] accumulate deletion and/or rearrangement
mutations with age. Some of the deletion mutations
that accumulate in humans with age are identical
with those that occur in human mitochondrial genet-
ic disease (Fig. 2). In humans, mtDNA mutations
accumulate preferentially in postmitotic tissues that
are oxidatively active [26] ; and aged brains cells of
the substantia nigra accumulate the highest levels of
mitochondrial mutation [38]. It is possible that the
higher level of deletion mutagenesis in these tissues is
the result of increased mitochondrial oxidative stress;
however, this has never been directly demonstrated.
These deletion mutations appear to be identical to
those observed in the mitochondrial disease
Kearns^Sayre’s syndrome [39^42], and appear to
rise exponentially with age [21,26,43^46].
4. Absolute frequency and distribution of age-related
mtDNA mutations
The highest mean concentration of any particular
deletion mutation, such as the 4977 deletion may be
maximally about 1% in any particular tissue homo-
genate, and if the 4977 deletion were evenly distrib-
uted and the only mtDNA deletion to accumulate
with age it is not clear if this would have a major
physiological e¡ect. However, it appears quite un-
likely that mtDNA mutations are evenly distributed;
data are more consistent with an uneven distribution
of mtDNA deletion mutations [47^49], as one might
expect from a somatic mutational process. Further
support for uneven distribution of age-related
mtDNA mutagenesis comes from a comparison of
apparent mtDNA mutation frequencies in DNA pre-
pared from cells vs. tissue homogenates using a
Fig. 2. Exponential accumulation of mitochondrial DNA dele-
tion mutations in mice and humans. Data redrawn from [50].
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quantitative assay [50] (see Fig. 3), in which muta-
tions were assayed from DNA prepared in two ways
from the same aged mouse hearts. From one heart
half DNA was prepared from homogenized tissue by
the standard phenol/chloroform extraction method.
From its sister half, cardiocyte cells were ¢rst disag-
gregated into pools of di¡ering sizes, pools of 300^
300 000 cardiocytes. The apparent deletion mutagen-
esis frequency is approximately 100-fold higher in the
identical amount of DNA made from homogenates
compared with cardiocytes, supporting the notion
that mtDNA deletion mutations occur in groups or
clusters.
5. Point mutations of mtDNA increase with age
Other deletion and/or rearrangement mutations in
addition to the 4977 deletion mutation have been
reported to rise with age (reviewed in [51]). Also, a
new method for total mtDNA ampli¢cation has been
developed that illustrates the rise of several mtDNA
deletions with age [24,25]; however, the assay is not
quantitative and thus could overestimate or under-
estimate the total fraction of mutant mtDNA ge-
nomes. Point mutations identical to pathogenic
mtDNA mutations have been reported to rise with
age [52^56], however, using a di¡erent mutation as-
say for a di¡erent point mutation; this increase was
not observed [57].
6. Biochemical analyses of mitochondrial function
with aging
Three major types of analysis of the contribution
of mitochondrial biochemical defects with age have
been carried out, including single enzyme analysis in
aging muscle ¢bers, analysis of the complete electron
transport chain or individual complexes, and analysis
of membrane potential with age.
A rise in cytochrome-oxidase-negative muscle ¢-
bers in humans over the age of 40 years has been
reported by multiple groups, [58^61], the data of
Byrne and Dennett are redrawn below (Fig. 4). These
data support an exponential rise in cytochrome-oxi-
dase-negative ¢bers, which are not observable in in-
dividuals under age 40 years, and which rise sharply
after age 40. Although it is known that muscle atro-
phy and dropout of muscle ¢bers does occur with
age, it is not clear if this is the result of loss of
cytochrome oxidase activity.
Fig. 3. Di¡erential apparent concentration of mtDNA deletions
in homogenates vs. cardiocytes is consistent with clustering of
mtDNA mutations. E. Wang and G.A. Cortopassi, unpublished
data. Upper panel : PCR of DNA extracted from cardiocytes
and ampli¢ed by method described in [50]. Lower panel : PCR
of DNA extracted from heart homogenates. The estimated
number of cells is indicated on the top of each gel. +, positive
control ; M, size marker.
Fig. 4. The incidence of cytochrome c oxidase-negative muscle
¢bers increases exponentially after the fourth decile of age.
Data redrawn from Byrne et al. [20,58].
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The second type of analysis of mitochondrial func-
tion with respect to age is the analysis of enzymatic
activity of the complete mitochondrial respiratory
chain and/or its four major electron transport units,
or the rate of ADP-stimulated molecular oxygen con-
sumption (i.e. state 3 respiration). In this category,
the majority of studies report an age-related decline
in electron transport chain activity, in mice, rats and
humans [62^70]. However two groups have observed
no decline in electron transport chain activity in ro-
dents [71^73].
The third type of analysis is to measure the mito-
chondrial membrane potential, the driving force
for ATP synthesis, in young and old animals. Meas-
urements of the mitochondrial membrane poten-
tial in young and old animals have supported
the view that there is decreased mitochondrial mem-
brane potential in mitochondria from aged species
[74^76].
7. Oxidant stress and mitochondria
Because approximately 90% of cellular oxygen is
consumed in mitochondria, and because approxi-
mately 3% of molecular oxygen is thought to escape
complete reduction to water, mitochondria are con-
sidered to be the major intracellular contributor to
superoxide generation, and perhaps to oxidant stress
in general. The potential involvement of oxidative
stress in aging has been suggested and reviewed else-
where [17,77]. It has been demonstrated that there is
an increased production of mitochondrial superoxide
and hydrogen peroxide from aged animals ([78,79]
and refs. therein). The results of knockout experi-
ments in mice con¢rm the importance of protection
from mitochondrially localized superoxide, in that
knockouts of the mitochondrial superoxide dismu-
tase are lethal [80,81].
Because the 13 polypeptides encoded by the
mtDNA are each involved in respiration, the most
likely e¡ect of age-related mtDNA mutagenesis is a
decrease or dysfunction of the respiratory chain. In-
hibition of the electron transport chain late in the
chain are expected to produce a more reduced elec-
tron transport chain. Since the majority of superox-
ide is thought to be generated by reaction of ubise-
miquinone radical with molecular oxygen, it would
be predicted that inhibition of the electron transport
chain should lead to increased superoxide generation.
We observe, like others, that the MERRF mutation
results in decreased oxygen consumption [82,83]. Us-
ing the reduction of cytochrome c to measure the
production of superoxide from submitochondrial
particles, we have measured the production of super-
oxide from submitochondrial particles prepared from
143B cells carrying the MERRF mtDNA vs. a con-
trol mtDNA. We observed that the MERRF muta-
tion results in about an 11% increase in mitochon-
drial in mean mitochondrial superoxide production
(Fig. 5, Hutchin, Attardi, and Cortopassi, unpub-
lished results). Whether this 11% increase in super-
oxide production is relevant for MERRF patho-
physiology is currently unknown.
8. Pure pathogenic MERRF, MELAS and LHON
mtDNA mutations can confer sensitivity to oxidant
stress
Although it is widely assumed that the phenotypic
e¡ects of inheritance of pathogenic mtDNA muta-
tions result from de¢cits in bioenergetic functions,
some alternative possibilities exist. For example, in
MERRF, it has been observed that resting [ATP]
levels are not any lower than in controls; however,
that cytoplasmic levels of Ca2 are higher in mutant
vs. control cells [84]. Thus, alternative models for the
pathophysiological mechanism of mitochondrial ge-
netic diseases might be entertained, including one in
which mitochondrial de¢cits sensitize cells to oxidant
and/or Ca2 stress. Thus, as a potential model of the
mechanism of pathogenesis in germline mtDNA dis-
ease, and also potentially in aging of the mtDNA, we
Fig. 5. Lower O2 consumption and higher superoxide produc-
tion from mutant MERRF than control mitochondria. T.P.
Hutchin, G. Attardi and G.A. Cortopassi, unpublished data.
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have tested the sensitivity of cells bearing the patho-
genic mitochondrial mutations LHON, MERRF,
and MELAS to an oxidative stress, exposure to hy-
drogen peroxide, as seen in Fig. 6 and [85]. The
MERRF, MELAS and LHON mutations each con-
ferred signi¢cant sensitivity to oxidant stress. It is
important for these data to be con¢rmed in other
transmitochondrial cell lines to know if this is a gen-
eral phenomenon. It is possible that the acceleration
of cell death by pathogenic mitochondrial mutations
is through increased activity of the apoptotic path-
way, which is known to involve mitochondria; how-
ever, there is not yet direct evidence for this possi-
bility. We observed rescue from death by depletion
by depletion of Ca2 from the tissue culture medium
and by depletion of intracellular Ca2 by treatment
with the intracellular Ca2 chelator BAPTA-AM.
Thus, it is possible that oxidant stress results in a
rise in intracellular Ca2 that is required for toxicity.
A potential downstream target of oxidant stress is
the mitochondrial permeability transition (see be-
low), which is sensitive to Ca2 and reactive oxygen
species and is inhibited by CsA [86]. It was observed
that CsA protected MERRF, MELAS and LHON
¢broblasts from oxidant stress, and speci¢cally more
than control cells.
9. Multiple lines of evidence implicate mitochondria in
cell death
Multiple lines of evidence have implicated mito-
chondria in the control of cell death, including the
localization of the anti-apoptotic protein Bcl-2 to the
outer mitochondrial membrane [87], and the require-
ment for mitochondria [88] and speci¢cally mito-
chondrial cytochrome c in cell-free systems of apop-
tosis [89], the early loss of mitochondrial membrane
potential in some forms of cell death [90,91], the
regulation of mitochondrial Ca2 by Bcl-2 [92], and
the inhibition of release of cytochrome c by Bcl-2
[93,94]. Currently the mechanism(s) by which cyto-
chrome c are released from mitochondria, and by
which Bcl-2 potentially inhibits the release of cyto-
chrome c from mitochondria are of signi¢cant inter-
est.
Fig. 6. Pathogenic mitochondrial mutations confer cellular sensitivity to oxidant stress. Redrawn from [85].
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10. The mitochondrial permeability transition has
been associated with cellular dysfunction and
death
The mitochondrial permeability transition (MPT)
is an abrupt rise in mitochondrial permeability that is
induced by Ca2 and reactive oxygen species, and
several other agents [86,95,96]. Cyclosporin A inhib-
its MPT, presumably by inhibiting the peptidyl-prol-
yl-isomerase of the mitochondrial cyclophilin to
which it binds [97]. Induction of the mitochondrial
permeability transition has recently been associated
with cell death [91,98]. Cytochrome c has recently
been demonstrated to be required for induction of
the biochemical hallmarks of apoptosis in some
cell-free systems [89,93,99]. One potential issue is
by what mechanism is cytochrome c released from
mitochondria to initiate apoptosis. Given the known
sensitivity of the MPT to several known toxins, a
straightforward question is to ask whether the induc-
tion of the MPT results in the release of cytochrome
c. We [99] and others [100] have observed that the
induction of the mitochondrial permeability transi-
tion is associated with the release of cytochrome c.
In Fig. 7, several known inducers of the MPT in
puri¢ed mitochondria were demonstrated to induce
the release of cytochrome c by Western blot. How-
ever, whether this release of cytochrome c occurs
speci¢cally, or by bursting of the outer mitochondrial
membrane is a relevant issue. We have observed that
osmotic support of puri¢ed mouse liver mitochon-
dria with PEG-1000 completely inhibited the release
of cytochrome c mediated by the standard MPT in-
ducers tBOOH, Ca2, and atractyloside. These re-
sults are most simply explained by PEG-mediated
suppression of mitochondrial bursting. However,
MPT-dependent mitochondrial bursting (i.e. non-
speci¢c release of cytochrome c) could be a physio-
logically relevant death mechanism, inasmuch as the
MPT inhibitor cyclosporin A does mediate protec-
tion from cell death in many experimental para-
digms. By contrast with the results with canonical
MPT inducers, we observed that dATP induced
a dose-dependent release of cytochrome c which
was not strongly inhibited by PEG, but was inhibit-
able by cyclosporin A, which potentially suggests an
independent release mechanism for cytochrome c
[78].
Fig. 7. Induction of the mitochondrial permeability transition causes release of apoptogenic cytochrome c, redrawn from [99]. Cyto-
chrome c is detected in supernatants from mitochondria induced for MPT by Western blot. Lane 1, control (uninduced). Lanes 2^13
are 6 pairs, the ¢rst sample of each pair is inducer alone, the second sample contains identical concentration of inducer plus 1 mM
cyclosporin A. The six lanes and inducers were: 2 and 3, 100 mM Ca2 ; 4 and 5, 5 mM atractyloside; 6 and 7, 100 mM tBOOH;
8 and 9, 5 mM MPP ; 10 and 11, 5 mM 1 mM H2O2 ; 12 and 13, 0.5 mM dATP. Lane 14, 0.3 mg of cytochrome c.
Fig. 8. Sample spectrophotometric recording showing the design
used for a comparison of rate of mitochondrial permeability
transition in young vs. old mice, redrawn from [78]. Numbers
on y-axis are absorbance, the induction of the mitochondrial
permeability transition results in increased light scattering. In-
duction mitochondria received Ca2 stimulus, control mitochon-
dria received no Ca2 stimulus, and inhibition samples received
Ca2 stimulus and cyclosporin A, a speci¢c inhibitor of the mi-
tochondrial permeability transition.
BBABIO 44703 5-2-99
G.A. Cortopassi, A. Wong / Biochimica et Biophysica Acta 1410 (1999) 183^193 189
11. Increased MPT inducibility in aged mouse
hepatocytes
Given the association of the MPT with cellular
pathophysiology, and the association between de¢cits
of mitochondrial dysfunction with age, one potential
issue is whether the MPT is more inducible with age.
In a recent comparison of MPT in young (1 month)
vs. old (36 month) liver mitochondria, lower state 3
respiration, higher state 4 respiration, and more in-
ducible MPT were observed in the old mitochondria
([79] and Fig. 8 below) which provides the ¢rst ex-
perimental support for the concept that MPT may be
more inducible in aged animals. Further research will
demonstrate whether or not these observations are
general in other strains and species. In Fig. 8 below,
the inducibility of MPT was measured as the di¡er-
ence in the rate of induction of swelling, which is
observed as an increased light scattering of the swol-
len mitochondria. The observed mouse liver MPT
was quite variable from day to day, but paired
same-day comparisons of old vs. young mice indi-
cated a statistically signi¢cantly faster MPT induc-
tion in old mice. This MPT was both Ca2 depend-
ent and cyclosporin A inhibitable.
12. Future prospects
Several lines of evidence indicate that there is a
decline in mitochondrial function with age at the
genetic, biochemical and bioenergetic level ; however,
to what extent these de¢cits of mitochondrial func-
tion underlie phenotypic changes that occur with
aging is still in an area of very active research.
Although it is clear that mitochondrial deletion mu-
tations rise exponentially with human age, and there
is substantial support for an association between
cox-negative ¢bers and mtDNA deletions, it is also
clear that there is a substantial number of cox-neg-
ative ¢bers in muscle that do not have detectable
mtDNA deletions. Although it is a reasonable hy-
pothesis, it is not yet clear whether mitochondrial
and or mtDNA damage is a cause of muscle atrophy,
or atrophy and death of other cell types with age.
Analytical techniques which globally and quantita-
tively assay mtDNA mutagenesis in a quantitative
way are needed to resolve this issue, as well as the
ability to assay such damage on aging human tissue
in situ.
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